E146: Did the Fed break the VC model? Plus IPOs, M&A, revaluing unicorns & more

Therapeutic Advances

The podcast explores groundbreaking therapeutic approaches for autoimmune diseases, highlighting a novel method involving glycosylation of antigens. David Friedberg explains how this technique introduces proteins into the liver, prompting the immune system to recognize them as safe, potentially resolving autoimmune conditions 1. This innovative approach could revolutionize treatment by offering a new modality beyond traditional immune suppression methods 2. Friedberg emphasizes the potential for developing specific therapeutics for various autoimmune diseases, marking a significant shift in medical science 3.

This represents a very novel and seemingly super impactful and powerful way to think about eliminating autoimmune disease going forward.

--- David Friedberg

The discussion underscores the transformative potential of these therapies in addressing genetic and environmental factors of autoimmune diseases.

   

Mechanisms Explored

The scientific mechanisms behind these new therapies are rooted in the immune system's ability to self-regulate. David Friedberg describes how regulatory T cells, or Treg cells, play a crucial role in preventing the immune system from attacking the body's own proteins 4. By presenting glycosylated proteins in the liver, the immune system is tricked into recognizing them as safe, halting autoimmune responses 5. This method has shown promise in animal models, stopping diseases like multiple sclerosis and type 1 diabetes in their tracks 1.

It's like friendly fire. Do not attack this protein.

--- David Friedberg

The potential to apply this technique to a wide range of autoimmune conditions could lead to significant advancements in treatment.